Loading…
Operates acute-care hospitals and a large network of behavioral health/psychiatric facilities across the US and UK.
Operates acute-care hospitals and a large network of behavioral health/psychiatric facilities across the US and UK.
Behavioral health facilities and acute-care hospitals are the two halves; behavioral care is paid mostly per patient day by insurers and state Medicaid programs, while acute hospitals depend on admissions and the mix of commercial insurance against government payers. It also operates psychiatric hospitals in the UK. Founder Alan Miller's family holds high-vote shares that give it control.
Moat: narrow (scale, installed base, regulatory licence). Largest US behavioral-health facility network plus acute-care scale gives referral and payer leverage.
Headquarters: King of Prussia, Pennsylvania, US · Founded: 1979 · Employees: 101,500
Size Universal Health Services (UHS) is a United States Health Care company (Hospital/Nursing Management) with a market value of $11.5B, the 716th largest of 3,117 United States companies the cockpit tracks. Shares closed at $195.50 on 6 Nov 2026.
Performance Over six months the shares gained 15.2%, against +12.8% for the median peer and -1.1% for the United States market (cap-weighted) — 7th highest of 15 in its peer set.
Growth Revenue grew 8.0% over the last twelve months (peer median +15.2%); the operating margin is 10.8% (peer median 13.6%).
Valuation It trades at 8.7× forward earnings against a peer median of 47.2× (cheapest of 15).
Price implies For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -10 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.6 points above its cost of capital (8.7% WACC).
Credit Universal Health Services has 6 bonds outstanding ($3.40B), rated BBB- by the agencies and trading like BBB- at a weighted spread of 115 bp.
Short interest Short interest is 5.1% of the free float (15 Oct 2026).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $18.4B | $17.4B | $15.8B | $14.3B | $13.4B |
| Revenue growth | — | +10% | +11% | +7% | — |
| Gross profit | $1.99B | $1.99B | $1.68B | $1.18B | $1.06B |
| EBITDA | $2.65B | $2.61B | $2.27B | $1.74B | $1.64B |
| Net income | $1.46B | $1.49B | $1.14B | $717M | $675M |
| Free cash flow | $1.12B | $849M | $1.12B | $525M | $262M |
| Capital expenditure | $941M | $1.02B | $944M | $743M | $734M |
| Total debt | $6.18B | $5.17B | $4.96B | $5.37B | $5.27B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Universal Health Services UHS | $11.5B | +15% | +8% | 11% | 8.7× | -1.2% |
| Acadia Healthcare ACHC | $3.44B | +47% | +4% | 10% | 18.7× | n/a |
| HCA Healthcare HCA | $103B | +14% | +6% | 15% | 16.2× | 3.3% |
| Tenet Healthcare THC | $22.5B | +49% | +6% | 17% | 14.0× | -1.2% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | UHS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +11.3% | +6.0% | 4th highest of 16 |
| 6-month return | +15.2% | +12.8% | 7th highest of 15 |
| Distance from 52-week high | -20.4% | -9.1% | 4th lowest of 16 |
| Revenue growth (TTM) | +8.0% | +15.2% | 7th lowest of 16 |
| Operating margin | 10.8% | 13.6% | 5th lowest of 16 |
| Forward P/E | 8.7× | 47.2× | cheapest of 15 |
| Growth the price implies (Req g, 7 yrs) | -1.2% | 14.3% | least demanding of 14 |
| Growth delivered (Del g) | +8.5% | +12.2% | 6th lowest of 14 |
| Hurdle (Req g minus delivered) | -9.7 pp | +6.0 pp | 2nd least demanding of 14 |
| ROIC minus cost of capital | +2.6 pp | -2.3 pp | 6th highest of 16 |
| EV / EBITDA | 6.7× | 27.2× | cheapest of 14 |
| Net debt / EBITDA | 2.3× | 1.6× | 6th most indebted of 14 |
| Bond spread | 115 bp | n/a | — |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Universal Health Services UHS | United States | $11.5B | +15% | +8% | 11% | 8.7× | -1.2% | +8.5% |
| Apollo Hospitals Enterprise APOLLOHOSP.NS | India | $12.8B | +8% | +19% | 12% | 49.3× | 32.2% | +19.0% |
| Max Healthcare Institute MAXHEALTH.NS | India | $9.61B | -8% | +15% | 21% | 49.7× | 43.2% | +27.2% |
| Manipal Health Enterprises MANIPALHOS.NS | India | $9.01B | n/a | +25% | 19% | 63.1× | 29.7% | +28.8% |
| Ramsay Health Care RHC.AX | Australia | $8.87B | +52% | +4% | 5% | 32.4× | 14.3% | +8.3% |
| PACS PACS | United States | $7.87B | +48% | +11% | 8% | 19.2× | 7.6% | +29.7% |
| Chemed CHE | United States | $6.87B | +24% | +5% | 14% | 19.5× | 2.4% | +4.0% |
| Aster DM Quality Care ASTERDM.NS | India | $6.57B | -3% | +16% | 14% | 49.6× | 55.3% | -11.6% |
| Fortis Healthcare FORTIS.NS | India | $6.13B | -19% | +18% | 17% | 45.0× | 41.0% | +17.9% |
| Tenet Healthcare THC | United States | $22.5B | +49% | +6% | 17% | 14.0× | -1.2% | +3.9% |
| Narayana Hrudayalaya NH.NS | India | $4.11B | +3% | +71% | 13% | 36.5× | 31.1% | +25.0% |
| Fresenius SE & Co. KGaA FRE.DE | Germany | $32.8B | +34% | +6% | 10% | 14.5× | 8.0% | -8.8% |
| Global Health MEDANTA.NS | India | $3.95B | +15% | +26% | 17% | 51.1× | n/a | n/a |
| National HealthCare NHC | United States | $3.27B | +11% | +7% | -8% | n/a | 7.9% | +9.7% |
| Krishna Institute of Medical Sciences KIMS.NS | India | $3.21B | +2% | +31% | 12% | 70.0× | n/a | n/a |
| Surgery Partners SGRY | United States | $2.99B | +61% | +4% | 14% | 62.5× | 13.8% | +12.2% |
Universal Health Services has 6 bonds outstanding with $3.40B face value. The agencies rate it BBB-; its bonds trade like BBB-. Weighted yield 5.80%, a spread of 115 bp over government bonds.